Prognostic value of serum cystatin C levels in cirrhotic patients with normal serum creatinine

[1] Garcia-Tsao G., Parikh C.R., Viola A. Acute kidney injury in cirrhosis. Hepatology, 2008, 48, 2064–2077 http://dx.doi.org/10.1002/hep.2260510.1002/hep.22605Search in Google Scholar

[2] Arroyo V., Colmenero J. Ascites and hepatorenal syndrome in cirrhosis. J. Hepatol., 2003, 38, 69–89 http://dx.doi.org/10.1016/S0168-8278(03)00007-210.1016/S0168-8278(03)00007-2Search in Google Scholar

[3] Arroyo V., Fernandez J., Gines P. Pathogenesis and treatment of hepatorenal syndrome. Semin. Liver Dis., 2008, 28, 81–95 http://dx.doi.org/10.1055/s-2008-104032310.1055/s-2008-1040323Search in Google Scholar

[4] Cholongitas E., Shusang V., Marelli L., Nair D., Thomas M., Patch D., Burns A., Sweny P., Burroughs A.K. Review article: renal function assessment in cirrhosis — difficulties and alternative measurements. Aliment. Pharmacol. Ther., 2007, 26, 969–971 http://dx.doi.org/10.1111/j.1365-2036.2007.03443.x10.1111/j.1365-2036.2007.03443.xSearch in Google Scholar

[5] Lopez-Hoyos M., San Segundo D., Benito M.J., Fernández-Fresnedo G., Ruiz J.C., Rodrigo E., Gómez-Alamillo C., Benito A., Arias M. Association between serum soluble CD30 and serum creatinine before and after renal transplantation. Transplant. Proc., 2008, 40, 2903–2905 http://dx.doi.org/10.1016/j.transproceed.2008.08.08710.1016/j.transproceed.2008.08.087Search in Google Scholar

[6] Mishra J., Ma Q., Prada A., Mitsnefes M., Yang J., Barasch J., Devarajan P. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol., 2003,14, 2534–2543 http://dx.doi.org/10.1097/01.ASN.0000088027.54400.C610.1097/01.ASN.0000088027.54400.C6Search in Google Scholar

[7] Parikh C.R., Abraham E., Ancukiewicz M., Edelstein C.L. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J. Am. Soc. Nephrol., 2005, 16, 3046–3052 http://dx.doi.org/10.1681/ASN.200503023610.1681/ASN.2005030236Search in Google Scholar

[8] Bonventre J.V. Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib. Nephrol., 2007, 156, 213–219 http://dx.doi.org/10.1159/00010208610.1159/000102086Search in Google Scholar

[9] Newman D.J., Thakkar H., Edwards R.G., Wilkie M., White T., Grubb A.O., Price C.P. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int.,1995,47, 312–318 http://dx.doi.org/10.1038/ki.1995.4010.1038/ki.1995.40Search in Google Scholar

[10] Randers E., Erlandsen E.J. Serum cystatin C as an endogenous marker of the renal function-a review. Clin. Chem. Lab. Med., 1999, 37, 389–395 http://dx.doi.org/10.1515/CCLM.1999.06410.1515/CCLM.1999.064Search in Google Scholar

[11] Demirtas S., Bozbas A., Akbay A., Akbay A., Yavuz Y., Karaca L. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin. Chim. Acta, 2001, 311, 81–89 http://dx.doi.org/10.1016/S0009-8981(01)00546-010.1016/S0009-8981(01)00546-0Search in Google Scholar

[12] Gerbes A.L., Gulberg V., Bilzer M., Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut, 2002, 50, 106–110 http://dx.doi.org/10.1136/gut.50.1.10610.1136/gut.50.1.106Search in Google Scholar

[13] Orlando R., Mussap M., Plebani M., Piccoli P., De Martin S., Floreani M., Padrini R., Palatini P. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin. Chem., 2002, 48, 850–858 10.1093/clinchem/48.6.850Search in Google Scholar

[14] Kim D.J., Kang H.S., Choi H.S., Cho H.J., Kim S.E., Keum B., An H., Kim J.H., Seo S.Y., Kim Y.S., Yim H.J., Jeen Y.T., Lee H.S., Um S.H., Kim C.D., Ryu H.S. Serum cystatin c level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels. The Korean Journal of Hepatology, 2011,17,130–138 http://dx.doi.org/10.3350/kjhep.2011.17.2.13010.3350/kjhep.2011.17.2.130Search in Google Scholar

[15] Chung M.Y., Jun D.W., Sung S.A. Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis. The Korean Journal of Hepatology,2010, 16, 301–307 http://dx.doi.org/10.3350/kjhep.2010.16.3.30110.3350/kjhep.2010.16.3.301Search in Google Scholar

[16] Ix J.H., Shlipak M.G., Chertow G.M., Whooley M.A. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation, 2007,115,173–179 http://dx.doi.org/10.1161/CIRCULATIONAHA.106.64428610.1161/CIRCULATIONAHA.106.644286Search in Google Scholar

[17] De Boer I.H., Katz R., Cao J.J., Fried L.F., Kestenbaum B., Mukamal K., Rifkin D.E., Sarnak M.J., Shlipak M.G., Siscovick D.S. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care, 2009, 32,1833–1838 10.2337/dc09-0191Search in Google Scholar

[18] Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg., 1973, 60, 646–649 http://dx.doi.org/10.1002/bjs.180060081710.1002/bjs.1800600817Search in Google Scholar

[19] Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., Kremers W., Lake J., Howard T., Merion R.M., Wolfe R.A., Krom R. Model for end-stage liver disease MELD and allocation of donor livers. Gastroenterology 2003,124, 91–96 http://dx.doi.org/10.1053/gast.2003.5001610.1053/gast.2003.50016Search in Google Scholar

[20] Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron, 1976, 16, 31–41 http://dx.doi.org/10.1159/00018058010.1159/000180580Search in Google Scholar

[21] Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med., 1999, 130, 461–470 http://dx.doi.org/10.7326/0003-4819-130-6-199903160-0000210.7326/0003-4819-130-6-199903160-00002Search in Google Scholar

[22] Proulx N.L., Akbari A., Garg A.X., Rostom A., Jaffey J., Clark H.D. Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol. Dial. Transplant,2005,20,1617–1622 http://dx.doi.org/10.1093/ndt/gfh83910.1093/ndt/gfh839Search in Google Scholar

[23] Seo Y.S., Jung E.S., An H., Kim J.H., Jung Y.K., Kim J.H., Yim H.J., Yeon J.E., Byun K.S., Kim C.D., Ryu H.S., Um S.H. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels. Liver Int.,2009,29,1521–1527 http://dx.doi.org/10.1111/j.1478-3231.2009.02105.x10.1111/j.1478-3231.2009.02105.xSearch in Google Scholar

[24] Fernández-Esparrach G., Sánchez-Fueyo A., Ginès P., Uriz J., Quinto L., Ventura P.J., Cardenas A., Guevara M., Sort P., Jimenez W., Bataller R., Arroyo V., Rodes J. A prognostic model for predicting survival in cirrhosis with ascites. J. Hepatol., 2001, 34, 46–52 http://dx.doi.org/10.1016/S0168-8278(00)00011-810.1016/S0168-8278(00)00011-8Search in Google Scholar

[25] Longheval G., Vereerstraeten P., Thiry P., Delhaye M., Le Moine O., Deviere J., Bourgeois N., Adler M. Predictive models of short- and long-term survival in patients with nonbiliary cirrhosis. Liver Transpl., 2003, 9, 260–267 http://dx.doi.org/10.1053/jlts.2003.5004910.1053/jlts.2003.50049Search in Google Scholar